Cyclic 2-amino-3-cyanothiophenes and derivatives for treatment of cancer

The invention encompasses compounds of formula (I) # imgabs0 # wherein R1a, R1b, R2a, R2b, Z, R3 to R5, A, p, L, U, V and W have the meanings given in the claims and the description; the use of said compounds as inhibitors of mutant Ras family proteins; pharmaceutical compositions and formulations c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HEDDES LARRY, PAN JING, WATSON ANDREW, CUI JIANWEN, BROCK, JOHN, HODGES TIM, WILDING, BJU RN, FISIK SCOTT W, MANTOULIDIS, APOSTOLOS, SMUTHURST CORNELIS ADRIANUS PETRUS, WUNBERG TOBIAS, EBT, J ¨ 1 RGEN, SARKAR DEEPAK, LITTLE ALEX, FOSS JOHN, RAMHARTER JUERGEN, SUN QI, TREU MARCEL
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention encompasses compounds of formula (I) # imgabs0 # wherein R1a, R1b, R2a, R2b, Z, R3 to R5, A, p, L, U, V and W have the meanings given in the claims and the description; the use of said compounds as inhibitors of mutant Ras family proteins; pharmaceutical compositions and formulations containing such compounds; and to the use of said pharmaceutical compositions and formulations as medicaments/medical, in particular as agents for the treatment and/or prophylaxis of carcinogenic diseases. 本发明涵盖式(I)化合物#imgabs0#其中R1a、R1b、R2a、R2b、Z、R3至R5、A、p、L、U、V及W具有权利要求书及说明书中所给出的含义;所述化合物作为突变体Ras家族蛋白质的抑制剂的用途;含有此类化合物的药物组合物及制剂;及所述药物组合物及制剂作为药剂/医疗用途,尤其作为用于治疗和/或预防致癌性疾病的试剂的用途。